Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 3/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | GBA1 | P04062 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CCR1 | P32246 | 1/20 | 0.39 |
| ▸ | CCR8 | P51685 | 1/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1219902 | 0.85 | CCR1 (0.41) | HSD11B1NPC1RAB9AGBA1TP53 | |
| SCHEMBL231108 | 0.82 | KDM4E (0.45) | TGFBR1HSD11B1NPC1RAB9AGBA1 | |
| SCHEMBL1219181 | 0.81 | RAB9A (0.40) | NPC1RAB9AGBA1CCR1CCR8 | |
| SCHEMBL1219522 | 0.81 | GRM5 (0.45) | TGFBR1HSD11B1NPC1RAB9AGBA1 | |
| SCHEMBL28509210 | 0.81 | KDM4E (0.44) | TGFBR1HSD11B1NPC1RAB9ATP53 | |
| SCHEMBL1219676 | 0.81 | HSD11B1 (0.48) | HSD11B1CCR1CCR8NOS3NOS2 | |
| SCHEMBL955795 | 0.80 | CCR1 (0.52) | NPC1RAB9ATP53CCR1CCR8 | |
| SCHEMBL1218757 | 0.79 | GRM5 (0.43) | TGFBR1NPC1RAB9AGBA1CCR1 | |
| SCHEMBL1217571 | 0.79 | KDM4E (0.50) | TGFBR1HSD11B1NPC1RAB9AGBA1 | |
| SCHEMBL2463151 | 0.77 | CCR1 (0.41) | NPC1RAB9AGBA1TP53CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2256102-B1 | PROCESS FOR PRODUCTION OF ALKOXYCARBONYL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2018-09-26 | — | — | EP | disclosed |
| EP-2828232-B1 | PROCESS FOR PRODUCING ALKYL METHACRYLATE | SUMITOMO CHEMICAL CO (JP) | 2016-04-20 | — | — | EP | disclosed |
| EP-2828232-A1 | PROCESS FOR PRODUCING ALKYL METHACRYLATE | Sumitomo Chemical Company Limited (JP) | 2015-01-28 | — | — | EP | disclosed |
| WO-2013141004-A1 | PROCESS FOR PRODUCING ALKYL METHACRYLATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-09-26 | — | — | WO | disclosed |
| US-8399699-B2 | Process for production of alkoxycarbonyl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20110046417-A1 | PROCESS FOR PRODUCTION OF ALKOXYCARBONYL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-24 | — | — | US | disclosed |
| EP-2256102-A1 | PROCESS FOR PRODUCTION OF ALKOXYCARBONYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046417-A1 | PROCESS FOR PRODUCTION OF ALKOXYCARBONYL COMPOUND | ADH1A, NAA50, NAA10 | TGFBR1 3715/4885HSD11B1 615/4885NPC1 2613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.